US FDA News: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions

FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions
Read more: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions